ViaPure

ViaPure was a biotechnology company focused on the development of high-performance purification technologies for viral vectors used in gene therapy and vaccine research. The company's primary offering was a proprietary chromatography-based platform designed to simplify and accelerate the purification of adenoviruses, providing a faster and more scalable alternative to traditional cesium chloride gradient centrifugation. Its technology was commercialized through specialized kits that enabled researchers to obtain high-titer, high-purity viral preparations with minimal hands-on time. ViaPure was eventually acquired by Mirus Bio, and its purification technology became a cornerstone of the Mirus Bio viral product portfolio.